Key facts
- Notable investors include Tidewater Capital Services, WorldUpstart, embARC Ventures (Tel Aviv).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Neshima Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Neshima Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neshima Medical
Manufacturer of a liquid foam respiratory drug delivery platform designed to treat severe lung diseases through improved pulmonary drug administration. The company offers patented liquid foam delivery technology for respiratory therapeutics, enabling patients with pneumonia, COPD, and other critical lung conditions to receive more effective and targeted treatment.
- Sector
- Healthcare
- HQ
- Dimona, Israel
- Founded
- 2020
- Employees
- 6
- Website
- neshimamedical.com/
- Ownership
- Privately Held (backing)
Neshima Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neshima Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neshima Medical in its N-PORT filings yet. We sweep new filings monthly.